Suche
Mein Konto
New hope for cancer patients: MedUni Vienna starts 24 million program!
On July 7, 2025, Vienna will present MedUni Vienna's new clinical research groups with 24 million euros in funding for patient-oriented medicine.
New hope for cancer patients: MedUni Vienna starts 24 million program!
On July 7, 2025, a new funding program from the Ludwig Boltzmann Society (LBG) was presented in Vienna, which focuses on patient-oriented topics in non-commercial clinical research. This program, known as Clinical Research Groups (KFG), was launched back in 2022 to fill an important gap in the field of clinical research. The funding totaling 24 million euros is provided by the Federal Ministry for Women, Science and Research (BMFWF) and the Future Austria Fund.
The event highlighted the three new clinical research groups focused on oncology and neurology. These KFGs are:
-
CRC Res
- Ziel: Bekämpfung von Therapieresistenzen bei Darmkrebs mit personalisierten Tumormodellen.
- Leitung: Johannes Längle von der Universitätsklinik für Allgemeinchirurgie, MedUni Wien.
-
StrikeBC
- Ziel: Verbesserung der Überlebenschancen und Lebensqualität von Menschen mit Blasenkrebs.
- Leitung: Bernhard Englinger von der Universitätsklinik für Urologie, MedUni Wien.
- EPICONN
- Ziel: Vorausschauende und personalisierte Behandlung für fokale Epilepsie.
- Leitung: Silvia Bonelli-Nauer von der Universitätsklinik für Neurologie, MedUni Wien.
The KFGs are funded for up to eight years, with up to around eight million euros being made available each. In the KFG CRC-Res, personalized tumor models are used to identify new therapeutic approaches. StrikeBC will collect relevant data from various sources to develop individualized treatment options for bladder cancer. In addition, EPICONN will specifically identify biomarkers in order to individualize the treatment of focal epilepsy and sustainably improve the quality of life of those affected. In the first phase of EPICONN, 300 people with focal epilepsy will be invited to participate.
Research funding in translational medicine
The importance of clinical research groups extends beyond pure funding. The aim of the funding is to intensify scientific collaboration between basic research and clinical application and thus also support translational research processes. Translational medicine deals with the implementation of research results into health care and requires close cooperation between different disciplines.
The foundations of translational medicine are exciting: Studies show that only a small proportion of new health research concepts find their way directly into clinical practice. This is where the KFG initiative comes into play, which promotes the exchange of knowledge between researchers, therapists and patients and focuses on improving health promotion, diagnosis and therapy, in the spirit of knowledge translation.
Long-term perspectives
The funding of such research groups does not only depend on monetary support, but also on the creation of structured training and cooperation opportunities within the clinics. The aim is to create a solid basis for clinical research and to familiarize the institutes intensively with the challenges and needs in patient care.
With the new funding program of the Ludwig Boltzmann Society and the three new clinical research groups, Vienna is taking a further step towards improved health care and showing how medical research and clinical practice can go hand in hand. The high level of financial support and the focus on patient-oriented topics can be seen as an example of promising medical research that aims to meet the high demands in the healthcare system.